As expected, anti-PD-1 monotherapy did not inhibit MCA205-EphA2 tumor growth, demonstrating its resistance to anti-PD-1 checkpoint therapy, whereas photoimmunotherapy treatment alone reduced tumor growth and extended survival. The gene discussed is EPHA2; the disease is neoplasm.